Galectin-Binding O-Glycosylations as Regulators of Malignancy
about
Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in CancerHallmarks of glycosylation in cancerMUC1 in lung adenocarcinoma: cross-sectional genetic and serological study.Synthetic Mucin-Like Glycopeptides as Versatile Tools to Measure Effects of Glycan Structure/Density/Position on the Interaction with Adhesion/Growth-Regulatory Galectins in Arrays.Silencing of ST6GalNAc I suppresses the proliferation, migration and invasion of hepatocarcinoma cells through PI3K/AKT/NF-κB pathway.Galectins: their network and roles in immunity/tumor growth control.Circulating blood and platelets supply glycosyltransferases that enable extrinsic extracellular glycosylation.Promoter SNPs rs116896264 and rs73933062 form a distinct haplotype and are associated with galectin-4 overexpression in colorectal cancer.Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkersRole of galectins in lung cancer.Evidence of Altered Glycosylation of Serum Proteins Prior to Pancreatic Cancer Diagnosis.Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.Prognostic significance of ST6GalNAc-1 expression in patients with non-metastatic clear cell renal cell carcinoma.Tumor cells interact with red blood cells via galectin-4 - a short report.A One-Step Chemoenzymatic Labeling Strategy for Probing Sialylated Thomsen-Friedenreich Antigen.Loss of GCNT2/I-branched glycans enhances melanoma growth and survivalGalectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans
P2860
Q26744538-CA6A1310-0C77-4395-853A-C32809B50832Q26752363-0490C799-CC6A-410F-AAB8-771AC84600C1Q33555885-237813B1-45B2-4889-9123-0E4CCD380F97Q36200747-26132CFB-D2F2-46A5-BFCA-388DAC570BDBQ38737068-566F2278-CEF2-405F-85A7-712F50A7CC95Q39052321-918BF954-B893-4E17-B1D7-130D66987AA5Q39231697-C9A259C2-0012-465A-A012-04754B0901BAQ40197366-11F19CC0-B7AF-43D4-80D1-41EBBE69E9C6Q42378844-72FB36B4-A3D7-4282-8C5D-C1A719D2ED6CQ47108427-AE2C58E7-9304-4E43-A7AE-C69EEDAEA3E2Q47177056-FAF0B93E-F7E6-4612-BFC9-1BB1A9050C12Q48026410-E9F356F4-E0DC-4933-A1B0-1DE514504CD4Q49293633-72A6F22D-C3E7-4446-94D6-C086914248C2Q52948746-4843034F-2F86-401C-BDCE-2DDE34CB8436Q55226110-010E7E90-355F-4AB9-98AD-2F8EF0F6694AQ58721942-140BADC4-EA84-419F-B082-85FB64AAF737Q58771173-26A6E96C-0608-4B37-9019-50F5EDEB262F
P2860
Galectin-Binding O-Glycosylations as Regulators of Malignancy
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Galectin-Binding O-Glycosylations as Regulators of Malignancy
@ast
Galectin-Binding O-Glycosylations as Regulators of Malignancy
@en
Galectin-Binding O-Glycosylations as Regulators of Malignancy
@nl
type
label
Galectin-Binding O-Glycosylations as Regulators of Malignancy
@ast
Galectin-Binding O-Glycosylations as Regulators of Malignancy
@en
Galectin-Binding O-Glycosylations as Regulators of Malignancy
@nl
prefLabel
Galectin-Binding O-Glycosylations as Regulators of Malignancy
@ast
Galectin-Binding O-Glycosylations as Regulators of Malignancy
@en
Galectin-Binding O-Glycosylations as Regulators of Malignancy
@nl
P2860
P3181
P1433
P1476
Galectin-Binding O-Glycosylations as Regulators of Malignancy
@en
P2093
Charles J Dimitroff
P2860
P304
P3181
P356
10.1158/0008-5472.CAN-15-0834
P407
P577
2015-08-15T00:00:00Z